ScholarIQanswers from OpenAlex

Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway

PaperCitations, authors & open-access status

Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway have?

ScholarIQcitation count

When was Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway published?

ScholarIQyear

Open the OpenAlex record →

What is the open-access status of Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway?

ScholarIQoa status

Open the OpenAlex record →

What is the DOI of Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway?

ScholarIQdoi

The DOI for Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway is on the source record.

Open the DOI →

What is the PMID of Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway?

ScholarIQpmid

The PMID for Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway is on the source record.

Open the PMID →

What is the OpenAlex record for Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway?

ScholarIQopenalex

The OpenAlex for Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF‐κB Signaling Pathway is on the source record.

Open the OpenAlex →

Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells <i>In Vitro</i> and <i>In Vivo</i> through Inhibiting the PI3K/AKT/mTOR/NF‐<i>κ</i>B Signaling Pathway

How many citations does Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells <i>In Vitro</i> and <i>In Vivo</i> through Inhibiting the PI3K/AKT/mTOR/NF‐<i>κ</i>B Signaling Pathway have?

When was Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells <i>In Vitro</i> and <i>In Vivo</i> through Inhibiting the PI3K/AKT/mTOR/NF‐<i>κ</i>B Signaling Pathway published?

What is the open-access status of Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells <i>In Vitro</i> and <i>In Vivo</i> through Inhibiting the PI3K/AKT/mTOR/NF‐<i>κ</i>B Signaling Pathway?

What is the DOI of Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells <i>In Vitro</i> and <i>In Vivo</i> through Inhibiting the PI3K/AKT/mTOR/NF‐<i>κ</i>B Signaling Pathway?

What is the PMID of Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells <i>In Vitro</i> and <i>In Vivo</i> through Inhibiting the PI3K/AKT/mTOR/NF‐<i>κ</i>B Signaling Pathway?

What is the OpenAlex record for Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells <i>In Vitro</i> and <i>In Vivo</i> through Inhibiting the PI3K/AKT/mTOR/NF‐<i>κ</i>B Signaling Pathway?

Related on ScholarIQ